Results 271 to 280 of about 498,550 (314)

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Cancer Cell, 2022
Yared Hailemichael, Noha Abdel-Wahab, Wai Chin Foo   +2 more
exaly  

Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

Cancer Cell, 2022
Namrata S Patil, Barzin Y Nabet, Soren Müller   +2 more
exaly  

Neuromuscular Blockade

Surgical Clinics of North America, 1975
openaire   +2 more sources

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses

Immunity, 2022
Karl L Banta, Xiaozheng Xu, Chikara Takahashi   +2 more
exaly  

Adrenergic blockade

American Heart Journal, 1960
openaire   +2 more sources

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell, 2020
Egmidio Medina, Katie M Campbell, Jason J Luke   +2 more
exaly  

The Blockade

2023
openaire   +1 more source

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Cancer Cell, 2021
Yuanyuan Zhang, Hongyan Chen, Hongnan Mo   +2 more
exaly  

Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Cancer Cell, 2020
Robert J Motzer, Thomas Powles, David F Mcdermott   +2 more
exaly  

CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma

Molecular Therapy, 2023
Zhi-Zhong Wu, Shu-Cheng Wan, Qi-Chao Yang   +2 more
exaly